Community management: A model that effectively reduces rate of medication discontinuation in patients with schizophrenia
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction
Patients with schizophrenia often experience high rates of medication interruptions, which have a range of serious consequences. Previous studies have shown that community management may help to address this situation.
Objective
To investigate treatment discontinuation in patients with schizophrenia under community management in China and analyze its associated factors.
Methods
The patients were assessed using a self-report questionnaire. The survey content included the following: treatment discontinuation, age, sex, education, residence, marital status, monthly family income, payment method for medication, employment, course of current disease, state of disease, insight, knowledge about drugs, types of drugs received, adverse effects of treatment, accepted follow-up, and family support.
Results
A total of 1531 patients with schizophrenia were included. Among them, 63 patients (4.1%) had discontinued medication at some point, while 1468 (95.9%) patients maintained treatment. The two groups showed statistically significant differences in payment methods for medication, state of disease, insight, knowledge about drugs, side effects of drugs, type of drugs received, and status of follow-up visits ( P <0.05). The results of the multivariate logistic regression analysis showed that the period of disease onset, lack of insight, obvious side-effects of drugs, and lack of follow-up were risk factors for patients to discontinue medication ( P <0.05).
Conclusion
Patients with schizophrenia under community management had a low rate of treatment discontinuation. The state of the disease, insight, side-effects of drugs, and status of follow-up visits are strongly related to medication interruption.
